United States
Germany
Japan
United Kingdom
China
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
Antibodies
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI7A2 (formerly 7A2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI5F3 (formerly 5F3)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)
| Applications | FC, IF, WB |
| Reactivities | Human, Dog, Rat, Monkey |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1D10 (formerly 1D10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI3C7 (formerly 3C7)
| Applications | FC, IF, WB |
| Reactivities | Human, Dog, Rat, Monkey |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI7A2 (formerly 7A2)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI4G1 (formerly 4G1)
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1B10 (formerly 1B10)
| Applications | FC, IF, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI5F3 (formerly 5F3)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI7C10 (formerly 7C10)
| Applications | FC, IF, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI1D10 (formerly 1D10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
MAPRE2 (EB2) mouse monoclonal antibody, clone OTI3C4 (formerly 3C4)
| Applications | FC, IF, WB |
| Reactivities | Human |
